Latest News

 Filter by Provider

Oracle has guided for tremendous revenue growth in its cloud infrastructure business over its next four fiscal years.

A $3,000 capital investment can buy the top Canadian stocks and create a mini-portfolio in 2026.

Some stocks can perform well even during a recession.

Nuvalent develops targeted therapies for drug-resistant cancers, advancing clinical-stage candidates in precision oncology.

The company recently unveiled its R2 lineup.

nLIGHT, a leader in advanced laser solutions for industry and defense, just reported a notable insider sale amid standout 1-year returns.

This clinical-stage biotech develops small-molecule therapies targeting NASH, obesity, and related metabolic diseases.

Seniors get a generous new tax deduction, but there's only a limited time to claim it.

Long-term dividend investors can take advantage of a rare combination of essential assets, a global footprint, and a steadily growing distribution in this stable stock.

Capstone Copper, VitalHub, and Electrovaya are profitable, fast-growing TSX stocks riding copper demand, healthcare tech, and the AI battery boom.

CoreWeave is posting incredible top-line growth, but its staggering costs and capital requirements make the stock too speculative for my portfolio.

This biotech develops Nanobody-based therapies targeting chronic inflammatory diseases in dermatology and rheumatology markets.

Uber said in a statement that it plans to launch a global fleet of entirely NVIDIA software-driven autonomous vehicles, starting in Los Angeles and San Francisco in the first half of 2027.

Impressed by the take-up of the company's stablecoin, an analyst upgraded his recommendation to buy.

Reliable dividend payers, like this regulated utility and this diversified financial, can keep cash coming in while the market sorts itself out.

The company reported a decline of 1% in its total revenue of $132.1 million in FY 25.

Nebius Group has emerged as a key player fueling AI infrastructure.

Intel stock swung dramatically on Monday.

Arcellx develops cell-based immunotherapies for cancer, leveraging proprietary platforms to address high unmet needs in oncology.

Live cattle futures saw Monday gains of $2.35 to $2.95 at the close. Cash trade settled in at $234-236 live last week, with some $372 dressed. Feeder cattle futures rallied $5.95 to $6.75 far on Monday. The CME Feeder Cattle Index was down another $1...

Corn futures posted 12 to 13 1/4 cent losses in the nearbys on Monday. Pressure is coming from beans and crude oil slipping $4.49. The CmdtyView national average Cash Corn price was down 13 cents to $4.11 1/2. Monday morning’s Export Inspections rep...

Cotton posted Monday gains of 206 to 234 points across the front months at the close, as traders came out of the weekend with a better feeling on the Chinese situation. Crude oil was down $4.49 to $94.22, with the US dollar index down $0.894 to $99.4...

Lean hog futures closed with mixed trade on Monday, as contracts were withing 20 cents of unchanged. USDA’s national base hog price was reported at $90.73 on Monday afternoon, down $1.09 from the day prior. The CME Lean Hog Index was another 16 cents...

Soybeans were down 60 to the 70 cent limit on Monday across the front months. Expanded limits of $1.05 are set for Tuesday. The cmdtyView national average Cash Bean price was down 70 1/2 cents at $10.80 3/4. Soymeal futures were down $5.10 to $11.50...

The wheat complex posted Monday losses across the three markets. Chicago SRW futures were 16 to 17 cents lower in the nearbys. KC HRW futures saw Monday weakness of 13 to 14 cents. MPLS spring wheat was down 10 to 12 cents at the close. Crude oil was...

This Dividend King is suddenly on sale. Should you buy the dip?

An analyst raised his price target on the beleaguered tech stock.

These beaten-down retail stocks could begin to grow on improved business performance and low valuations.

Competition has been intensifying in the electric vehicle market, and that has resulted in some lackluster results for Tesla in recent quarters.

It's smart for investors to consider ways to build their portfolios with exposure to AI.

TruBridge said that it requires additional time for the completion of its year-end audit procedures.

AI data centers have a need for speed.

Nvidia's GTC conference delivered big news, but the stock couldn't hold onto its early gains.

Nvidia CEO Jensen Huang said the $1 trillion figure Monday during GTC 2026. Here's what the figure means.

Cboe is preparing to launch in December 2026, pending regulatory approval of its filing, and contingent upon the readiness of required industry infrastructure providers.

Devon Energy is quietly building one of the most durable shareholder-return stories in U.S. shale: ultra-low production costs, billions in free cash flow, and a pending Coterra merger that could lift the dividend and supercharge buyback.

New Era Energy & Digital said it has appointed Ted Warner as Chief Financial Officer, effective March 16, 2026.

Ethereum believers should take a look at this stock.

Kaltura (KLTR) Q4 2025 Earnings Call Transcript

Olema Pharmaceuticals develops targeted therapies for women's cancers, with a lead candidate in clinical trials for breast cancer treatment.

Both of these Canadian Bank ETFs employ leverage and covered calls to deliver 10-14% yields.